Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Diagnostic Yield and Safety of Lung Biopsy Techniques in Interstitial Lung Diseases

NCT07432503
completednot_applicable

The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer

NCT05164445
unknownnot_applicable

The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGO

NCT04727190

Clinical Trials (3)

Showing 3 of 3 trials
NCT07432503Not Applicable

Diagnostic Yield and Safety of Lung Biopsy Techniques in Interstitial Lung Diseases

Completed
NCT05164445Not Applicable

The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer

Completed
NCT04727190Not Applicable

The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGO

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3